Therapeutic Adherence

  • Bruce J. Masek
  • William R. Jankel


It is our intent in this chapter to examine the problem of therapeutic nonadherence in pediatrics. Research with adult populations will only be considered in the absence of illustrative examples from the pediatric literature. We will discuss methodological issues including definitional and measurement difficulties that have hampered progress in developing effective solutions for nonadherence. The research that has attempted to identify the causes of nonadherence and treatments for nonadherence will also be reviewed. The remainder of the chapter will focus on a review by disease entity of the pediatric research in the area that is noteworthy for innovation and/or objectivity in its approach to the assessment and treatment of nonadherence. We have chosen to review the majority of pediatric research by disease entity for the sake of convenience and to identify and integrate with medical management of the disease the salient variables from an applied behavior analysis perspective relevant to assessing and treating nonadherence. Finally we offer some guidelines for future inquiries in this important area of behavioral pediatrics research.


Cystic Fibrosis Anorexia Nervosa Therapeutic Regimen Medical Regimen Rheumatic Fever 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Alpert, J. J. Broken appointments. Pediatrics, 1964, 34, 127–132.PubMedGoogle Scholar
  2. Ayllon, T., & Azrin, N. H. The token economy. New York: Appleton-Century- Crofts, 1968Google Scholar
  3. Azrin, N. H., & Powell, J. Behavioral engineering: The use of response priming to improve prescribed self-medication. Journal of Applied Behavior Analysis, 1969, 2, 39–42.PubMedCrossRefGoogle Scholar
  4. Becker, M. H., Drachman, R. H., & Kirscht, J. P. Predicting mothers’ compliance with pediatric medical regimen. Journal of Pediatrics, 1972, 81, 843–854.PubMedCrossRefGoogle Scholar
  5. Bergman, A. R., & Werner, R. J. Failure to receive penicillin by mouth. New England Journal of Medicine, 1963, 268, 1334–1338.PubMedCrossRefGoogle Scholar
  6. Bigelow, G., Strickler, D., Liebson, I., & Griffiths, R. Maintaining disulfiram ingestion among outpatient alcoholics: A security deposit contingency contracting procedure. Behaviour Research and Therapy, 1976, 14, 378–381.PubMedCrossRefGoogle Scholar
  7. Blackwell, B. Drug therapy: Patient compliance. New England Journal of Medicine, 1973, 289, 249–252.PubMedCrossRefGoogle Scholar
  8. Blackwell, B. Treatment adherence in hypertension. American Journal of Pharmacy, 1976, 148, 75–85.Google Scholar
  9. Bochner, F., Hooper, W. D., Sutherland, J. M., Eadie, M. J., & Tyler, J. H. Diphenylhydantoin concentration in saliva. Archives of Neurology, 1974, 31, 57–59.PubMedCrossRefGoogle Scholar
  10. Breese, B. B., Disney, F. A., Talpey, W. P., Green, J. L., & Tobin, J. Streptococcal infections in children: Comparison of the therapeutic effectiveness of erythromycin administered three times daily. American Journal of Diseases of Childhood, 1974, 128, 457–461.Google Scholar
  11. Brett, E. Implications of measuring anticonvulsant blood levels in epilepsy. Developmental Medicine and Child Neurology, 1977, 19, 245–251.PubMedCrossRefGoogle Scholar
  12. Buchanan, N., Shuenyane, E., Mashigo, S., Mtangai, P., & Unterhalter, B. Factors influencing drug compliance in ambulatory black urban patients. South African Medical Journal, 1979, 55, 368–373.PubMedGoogle Scholar
  13. Caloza, D. L., Fields, L. A., & Bernfeld, G. E. Discontinuous antibiotic therapy for urinary tract infections. Scandinavian Journal of Infectious Diseases, 1978, 10, 75–78.PubMedGoogle Scholar
  14. Carnahan, J. E., & Nugent, C. A. The effects of self-monitoring by patients on the control of hypertension. The American Journal of the Medical Sciences, 1975, 269, 69–73.PubMedCrossRefGoogle Scholar
  15. Charney, E., Bynum, R., Eldredge, D., Frank, D., MacWhinney, J. B., McNab, M., Scheiner, A., Sumpter, E., & Iker, H. How well do patients take oral penicillin? Pediatrics, 1967, 40, 188–195.PubMedGoogle Scholar
  16. Cocks, D. A., Critchley, E. M., Hayward, H. W., Owen, V., Mawer, G. E., & Woodcock, B. G. Control of epilepsy with a single dose of phenytoin sodium. British Journal of Clinical Pharmacology, 1975, 2, 449–453.PubMedCrossRefGoogle Scholar
  17. Colcher, I. S., & Bass, J. W. Penicillin treatment of streptococcal pharyngitis: A comparison of schedules and the role of specific counseling. Journal of the American Medical Association, 1972, 222, 657–659.PubMedCrossRefGoogle Scholar
  18. Cook, C. E., Anderson, E., Poole, W. K., Lesser, P., & O’Tuama, L. Phenytoin and phenobarbital concentrations in saliva and plasma measured by radioimmunoassay. Clinical Pharmacology and Therapeutics, 1975, 18, 742–747.PubMedGoogle Scholar
  19. Culliton, B. J. Health care economics: The high cost of getting well. Science, 1978, 200, 883–885.PubMedCrossRefGoogle Scholar
  20. Daschner, F., & Marget, W. Treatment of recurrent urinary tract infection in children. Acta Pediatrica Scandinavica, 1975, 64, 105–108.CrossRefGoogle Scholar
  21. Davidoff, F. Compliance with antihypertensive therapy: The last link in the chain. Connecticut Medicine, 1976, 40, 378–383.PubMedGoogle Scholar
  22. Davidson, M., Kugler, M. M., & Bauer, C. H. Diagnosis and management in children with severe and protracted constipation and obstipation. Journal of Pediatrics, 1963, 62, 261.PubMedCrossRefGoogle Scholar
  23. Davis, M. S. Variations in patients’ compliance with doctor’s orders: Analysis of congruence between survey responses and results of empirical investigations. Journal of Medical Education, 1966, 41, 1037–1048.Google Scholar
  24. Derrick, C. W., & Dillon, H. C. Streptococcal pharyngitis: Comparisons of therapeutic agents b.i.d. and q.i.d. Clinical Research, 1973, 21, 120–126.Google Scholar
  25. Easson, W. M. Encopresis—Psychogenic soiling. Journal of the Canadian Medical Association, 1960, 82, 624.Google Scholar
  26. Elling, R., Whittemore, R., & Green, M. Patient participation in a pediatric program. Journal of Health and Human Behavior, 1960, 1, 183–191.CrossRefGoogle Scholar
  27. Eney, R. D., & Goldstein, M. D. Compliance of chronic asthmatics with oral administration of theophylline as measured by serum and salivary levels. Pediatrics, 1976, 57, 513–517.PubMedGoogle Scholar
  28. Epstein, L. H., & Masek, B. J. Behavioral control of medicine compliance. Journal of Applied Behavior Analysis, 1978, 11, 1–9.PubMedCrossRefGoogle Scholar
  29. Evans, R. I. Smoking in children: Developing a social psychological strategy of deterrence. Preventive Medicine, 1976, 5, 122–127.CrossRefGoogle Scholar
  30. Francis, V., Korsch, B., & Morris, M. Gaps in doctor–patient communication: Patient’s response to medical advice. New England Journal of Medicine, 1969, 280, 535–540.PubMedCrossRefGoogle Scholar
  31. Freeman, J. Personal communication, June 1978.Google Scholar
  32. Freiman, J., & Buchanan, N. Drug compliance and therapeutic considerations in 75 black epileptic children. Central African Journal of Medicine, 1978, 24, 136–140.PubMedGoogle Scholar
  33. Gabriele, A. J., & Marble, A. Experiences with 116 juvenile campers in a new summer camp for diabetic boys. American Journal of Medical Science, 1948, 218, 161–171.CrossRefGoogle Scholar
  34. Gabrielson, I. W., Levin, L. S., & Ellison, M. D. Factors affecting school health follow-up. American Journal of Public Health, 1967, 57, 48–59.PubMedCrossRefGoogle Scholar
  35. Gordis, L. Conceptual and methodological problems in measuring patient compliance. In R. B. Haynes, D. W. Taylor, & D. L. Sackett (Eds.), Compliance in health care. Baltimore: Johns Hopkins University Press, 1979.Google Scholar
  36. Gordis, L., & Markowitz, M. Evaluation of the effectiveness of comprehensive and continuous pediatric care. Pediatrics, 1971, 48, 766–776.PubMedGoogle Scholar
  37. Gordis, L., Markowitz, M., & Lilienfeld, A. M. Why patients don’t follow medical advice: A study of children on long-term antistreptococcal prophylaxis. Journal of Pediatrics, 1969, 75, 957–968.PubMedCrossRefGoogle Scholar
  38. Gray, R. M., Kesler, J. P., & Moody, P. M. The effects of social class and friends’ expectations on oral polio vaccination participation. American Journal of Public Health, 1966, 56, 2028–2032.PubMedCrossRefGoogle Scholar
  39. Gundert-Remy, U., Remy, C., & Weber, E. Serum digoxin levels in patients of a general practice in Germany. European Journal of Clinical Pharmacy, 1976, 10, 97–100.Google Scholar
  40. Haynes, R. B. Determinants of compliance: The disease and the mechanics of treatment. In R. B. Haynes, D. W. Taylor, & D. L. Sackett (Eds.), Compliance in health care. Baltimore: Johns Hopkins University Press, 1979.Google Scholar
  41. Haynes, R. B., Sackett, D. L., Gibson, E. S., Taylor, D. W., Hackett, B. C., Roberts, R. S., & Johnson, A. L. Improvement of medication compliance in uncontrolled hypertension. Lancet, 1976, 1, 1265–1268.PubMedCrossRefGoogle Scholar
  42. Haynes, R. B., Taylor, D. W., & Sackett, D. L. (Eds.). Compliance in health care. Baltimore: Johns Hopkins University Press, 1979.Google Scholar
  43. Heinzelmann, F. Factors in prophylaxis behavior in treating rheumatic fever: An exploratory study. Journal of Health and Human Behavior, 1962, 3, 73–81.CrossRefGoogle Scholar
  44. Hobby, G. K., & Deuschle, K. W. The use of riboflavin as an indicator of isoniazid ingestion in self-medicated patients. American Review of Respiratory Diseases, 1959, 80, 415–423.Google Scholar
  45. Holliday, M. A. Calorie deficiency in children with uremia: Effect upon growth. Pediatrics, 1972, 50, 590.Google Scholar
  46. Korsch, B. M., Gozzi, E. K., & Francis, V. Gaps in doctor—patient communication: I. Doctorpatient interaction and patient satisfaction. Pediatrics, 1968, 42, 855–869.PubMedGoogle Scholar
  47. Kutt, H. The use of blood levels of antiepileptic drugs in clinical practice. Pediatrics, 1974, 53, 557–559.PubMedGoogle Scholar
  48. Levine, M. D. Children with encopresis: A descriptive analysis. Pediatrics, 1975, 56, 412–417.PubMedGoogle Scholar
  49. Levine, M. D., & Bakow, H. Children with encopresis: A study of treatment outcome. Pediatrics, 1976, 58, 845–852.PubMedGoogle Scholar
  50. Linkewich, J. A., Catalano, R. B., & Flack, H. L. The effect of packaging and instruction on outpatient compliance with medication regimens. Drug Intelligence and Clinical Pharmacy, 1974, 8, 10–15.Google Scholar
  51. Lowe, K., & Lutzker, J. R. Increasing compliance to a medical regimen with a juvenile diabetic. Behavior Therapy, 1979, 10, 57–64.CrossRefGoogle Scholar
  52. Lund, L. Effects of phenytoin in patients with epilepsy in relation to its concentration in the plasma. In D. S. Davies & B. N. C. Prichard (Eds.), Biological effects of drugs in relation to their plasma concentration. London: Macmillan, 1973.Google Scholar
  53. Lund, M., Jorgensen, R. S., & Kuhl, V. Serum diphenylhydantoin (Dilantin) in ambulant patients with epilepsy. Epilepsia, 1964, 5, 51–58.PubMedCrossRefGoogle Scholar
  54. Macdonald, M. E., Hagberg, K. L., Sr Grossman, B. J. Social factors in relation to partic-ipation in follow-up care of rheumatic fever. Journal of Pediatrics, 1963, 62, 503–513.Google Scholar
  55. Magrab, P. R., & Papadopoulou, Z. L. The effect of a token economy on dietary compliance for children on hemodialysis. Journal of Applied Behavior Analysis, 1977, 10, 573–578.PubMedCrossRefGoogle Scholar
  56. Marston, M. V., Compliance with medical regimens: A review of literature. Nursing Re-search, 1970, 19, 312–323.Google Scholar
  57. Masek, B. J. Compliance and medicine. In D. M. Doleys, R. L. Meredith, Sr A. R. Ciminero (Eds.), Behavioral medicine: Assessment and treatment strategies. New York: Plenum Press, 1982.Google Scholar
  58. Masek, B. J., Epstein, L. H., & Russo, D. C. Behavioral perspectives in preventive medicine. In S. M. Turner, K. S. Calhoun, & H. E. Adams (Eds.), Handbook of clinical behavior therapy. New York: Wiley, 1981.Google Scholar
  59. Mattar, M. E., & Yaffe, S. J. Compliance of pediatric patients with therapeutic regimens. Postgraduate Medicine, 1974, 56, 181–188.PubMedGoogle Scholar
  60. McKenney, J. M., Slining, J. M., Henderson, H. R., Devins, D., Sr Barr, M. The effect of clinical pharmacy services on patients with essential hypertension. Circulation, 1973, 48, 1104–1111.PubMedCrossRefGoogle Scholar
  61. Melchoir, J. C. The clinical use of serum determinants of phenytoin and phenobarbital in children. Developmental Medicine and Child Neurology, 1965, 7, 387–391.CrossRefGoogle Scholar
  62. Meyers, A., Dolan, T. F., & Mueller, D. Compliance and self-medication in cystic fibrosis. American Journal of Diseases of Children, 1975, 129, 1011–1013.PubMedGoogle Scholar
  63. Mohler, D. N., Wallin, D. G., Sr Dreyfus, E. G. Studies in the home treatment of strep-tococcal pneumonia. New England Journal of Medicine, 1955, 252, 1116–1118PubMedCrossRefGoogle Scholar
  64. Mucklow, J. C., & Dollery, C. T. Compliance with anticonvulsive therapy in a hospital clinic and in the community. British Journal of Clinical Pharmacology, 1978, 6, 75–79.PubMedCrossRefGoogle Scholar
  65. Normand, J. C. S., & Smellie, J. M. Prolonged maintenance chemotherapy in the man-agement of urinary infection in children. British Medical Journal, 1965, 1, 1023.PubMedCrossRefGoogle Scholar
  66. Pinkerton, P. Psychogenic megacolon in children: The implications of bowel negativism. Archives of Disease in Childhood, 1958, 33, 371.CrossRefGoogle Scholar
  67. Porter, A. M. W. Drug defaulting in a general practice. British Medical Journal, 1969, 1, 218–222.PubMedCrossRefGoogle Scholar
  68. Pryles, C. V., Wherrett, B. A., & McCarthy, J. M. Urinary tract infections in infants and children: Long term prospective study: Interim report on results of six weeks chemotherapy. American Journal of Diseases of Children, 1964, 108, 1–13.PubMedGoogle Scholar
  69. Rapoff, M. A., & Christophersen, E. R. Compliance with medical regimens: A review and evaluation. Paper presented at the Banff International Conference on Behavioral Medicine, Banff, Alberta, Canada, March 1980.Google Scholar
  70. Reynolds, E. H. Drug treatment of epilepsy. Lancet, 1978, 3, 721–725.CrossRefGoogle Scholar
  71. Reynolds, E. H., Chadwick, D., & Galbraith, A. W. One drug (phenytoin) in the treatment of epilepsy. Lancet, 1976, 1, 923.PubMedCrossRefGoogle Scholar
  72. Richens, A. Quality control of drug estimations. Acta Neurologica Scandinavia’, 1975 (Supplement), 60, 81–84.Google Scholar
  73. Ruley, E. J. Compliance in young hypertensive patients. Pediatric Clinics of North America, 1978, 25, 175–182.PubMedGoogle Scholar
  74. Russo, D. C., Bird, B. L., & Masek, B. J. Assessment issues in behavioral medicine. Behavioral Assessment, 1980, 2, 1–18.CrossRefGoogle Scholar
  75. Sackett, D. L., & Haynes, R. B. (Eds.). Compliance with therapeutic regimens. Baltimore: Johns Hopkins University Press, 1976.Google Scholar
  76. Sackett, D. L., & Snow, J. C. The magnitude of compliance and noncompliance. In R. B. Haynes, D. W. Taylor, & D. L. Sackett (Eds.), Compliance in health care. Baltimore: Johns Hopkins University Press, 1979.Google Scholar
  77. Sackett, D. L., Haynes, R. B., Gibson, E. S., Hackett, B. C., Taylor, D. W., Roberts, R. S., & Johnson, A. L. Randomised clinical trial of strategies for improving medication compliance in primary hypertension. Lancet, 1975, 1, 1205–1207.PubMedCrossRefGoogle Scholar
  78. Shapera, R. M., Hable, K. A., & Matsen, J. M. Erythromycin therapy twice daily for streptococcal pharyngitis: Controlled comparison with erythromycin or penicillin phenoxymethyl four times daily or penicillin G benzathine. Journal of the American Medical Association, 1973, 226, 531–537.PubMedCrossRefGoogle Scholar
  79. Sharpe, T. R., & Mikeal, R. L. Patient compliance with antibiotic regimens. American Journal of Hospital Pharmacy,1974„31, 479–484.Google Scholar
  80. Sherwin, A. L., Robb, J. P., & Lechter, M. Improved control of epilepsy by monitoring plasma ethosuximide. Archives of Neurology, 1973, 28, 178–181.PubMedCrossRefGoogle Scholar
  81. Simonds, J. F. Study of diabetic attitudes in children and parents. In Seventh allied health postgraduate course in diabetes. Kansas City, Mo.: American Diabetes Association, 1975.Google Scholar
  82. Simonds, J. F. Emotions and compliance in diabetic children. Psychosomatics, 1979, 20, 544–551.PubMedGoogle Scholar
  83. Soutter, R. B., & Kennedy, M. C. Patient compliance assessment in drug trials: Usage and methods. Australian and New Zealand Journal of Medicine, 1974, 4, 360–364.PubMedCrossRefGoogle Scholar
  84. Stansfeld, J. M., & Webb, J. K. G. Plea for longer treatment of chronic pyelonephritis in children. British Medical Journal, 1954, 1, 616.PubMedCrossRefGoogle Scholar
  85. Stuart, R. B., & Davis, B. Slim chance in a fat world: Behavioral control of obesity. Champaign, Ill.: Research Press, 1972.Google Scholar
  86. Stunkard, A. J. New therapy for the eating disorders: Behavior modification of obesity and anorexia nervosa. Archives of General Psychiatry, 1972, 26, 391–398.CrossRefGoogle Scholar
  87. Weintraub, M., Au, W. Y. W., & Lasagna, L. Compliance as a determinant of serum digoxin concentration. Journal of the American Medical Association, 1973, 224, 481–485.PubMedCrossRefGoogle Scholar
  88. Wilson, C. J., Potter, D. E., & Holliday, M. A. Treatment of uremic child. In R. W. Wiaters (Ed.), Body fluids in pediatrics. Boston: Little, Brown, 1973.Google Scholar

Copyright information

© Springer Science+Business Media New York 1982

Authors and Affiliations

  • Bruce J. Masek
    • 1
  • William R. Jankel
    • 2
  1. 1.Children’s Hospital Medical CenterHarvard Medical SchoolBostonUSA
  2. 2.John F. Kennedy InstituteJohns Hopkins University School of MedicineBaltimoreUSA

Personalised recommendations